Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Panbela Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of PBLA Stock
United States Health Care Nano Cap Yes. As of November 2026, Panbela Therapeutics Inc (PBLA) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Panbela Therapeutics Inc passes Musaffa's business and financial screening criteria.
Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. The company is headquartered in Waconia, Minnesota and currently employs 7 full-time employees. The company went IPO on 2014-07-29. The firm is developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company’s lead candidates are ivospemin (SBP-101), for which it has licensed the worldwide rights from the University of Florida Research Foundation, Inc., Flynpovi, a combination of eflornithine (CPP-1X) and sulindac and eflornithine (CPP-1X), alone in tablet or sachet form. The company has licensed rights from the Arizona Board of Regents of the University of Arizona to commercialize Flynpovi. Additionally, eflornithine is being evaluated with high dose testosterone and enzalutamide in metastatic castration-resistant prostate cancer in a phase II trial. The firm is engaged in over two sponsored research agreements to evaluate the polyamines individually and combined for various diseases.
PBLA Shariah Compliance
Screening Methodology: AAOIFI
As of November 2026, Panbela Therapeutics Inc is classified as halal.
HALALPanbela Therapeutics Inc (PBLA) Chart
Fetching Price Chart...
Financial Metrics & Statements of Panbela Therapeutics Inc (PBLA)
FAQ's for Panbela Therapeutics Inc (PBLA)
- As of November 2026, Panbela Therapeutics Inc PBLA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Panbela Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Panbela Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Panbela Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Panbela Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Panbela Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Panbela Therapeutics Inc (PBLA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
